CN Stock MarketDetailed Quotes

Sichuan Kelun Pharmaceutical (002422)

Watchlist
  • 44.17
  • -0.91-2.02%
15min DelayTrading Nov 9 14:21 CST
70.26BMarket Cap35.71P/E (TTM)

Sichuan Kelun Pharmaceutical (002422) Income Statement

Quarterly·All
YOY yoy
Hide blank lines yoy
Currency: CNY
2026/Q9
2026/H1
2026/Q1
2025/FY
2025/Q9
2025/H1
2025/Q1
2024/FY
2024/Q9
2024/H1
2024/Q1
2023/FY
2023/Q9
2023/H1
2023/Q1
2022/FY
2022/Q9
2022/H1
2022/Q1
2021/FY
Total Operating Revenue
-1.24%13.11B
-2.70%8.84B
-2.98%4.26B
-15.13%18.51B
-20.92%13.28B
-23.20%9.08B
-29.42%4.39B
+1.67%21.81B
+6.64%16.79B
+9.52%11.83B
+10.32%6.22B
+12.69%21.45B
+12.93%15.74B
+18.35%10.80B
+25.79%5.64B
+10.19%19.04B
+9.88%13.94B
+10.84%9.12B
+7.97%4.48B
+4.94%17.28B
Operating Revenue
-1.24%13.11B
-2.70%8.84B
-2.98%4.26B
-15.13%18.51B
-20.92%13.28B
-23.20%9.08B
-29.42%4.39B
+1.67%21.81B
+6.64%16.79B
+9.52%11.83B
+10.32%6.22B
+12.69%21.45B
+12.93%15.74B
+18.35%10.80B
+25.79%5.64B
+10.19%19.04B
+9.88%13.94B
+10.84%9.12B
+7.97%4.48B
+4.94%17.28B
Other Operating Revenues
----
+3.35%312.70M
----
-8.10%648.53M
----
-16.87%302.55M
----
-4.59%705.65M
----
-0.83%363.93M
----
+69.01%739.64M
----
+82.92%366.98M
----
+28.25%437.62M
----
+17.72%200.62M
----
+1.38%341.23M
Total Operating Cost
+1.16%12.00B
+3.87%8.12B
+7.03%3.99B
-7.93%16.44B
-11.56%11.86B
-15.34%7.82B
-21.81%3.73B
-2.33%17.85B
-0.41%13.41B
+0.92%9.24B
+2.42%4.77B
+6.12%18.28B
+8.85%13.47B
+11.36%9.15B
+9.94%4.65B
+5.73%17.22B
+3.30%12.37B
+5.17%8.22B
+4.86%4.23B
+3.46%16.29B
Cost of Sales
-0.30%6.90B
+1.54%4.63B
+3.37%2.33B
-8.37%9.66B
-13.22%6.92B
-16.42%4.56B
-17.96%2.25B
+3.25%10.54B
+7.61%7.97B
+7.95%5.46B
+7.68%2.75B
+12.89%10.21B
+15.99%7.41B
+20.96%5.06B
+21.52%2.55B
+18.02%9.04B
+13.99%6.39B
+15.70%4.18B
+12.05%2.10B
+1.69%7.66B
Operating Tax Surcharges
+1.29%189.46M
+9.56%133.09M
+32.61%70.65M
-6.65%257.85M
-10.46%187.05M
-11.40%121.49M
-16.45%53.28M
-8.75%276.22M
-10.25%208.89M
-11.17%137.12M
+0.25%63.76M
+20.51%302.73M
+27.62%232.75M
+39.70%154.35M
+18.08%63.60M
+12.23%251.20M
+12.68%182.37M
+7.82%110.48M
+11.59%53.86M
+12.61%223.82M
Operating Expense
+9.56%2.35B
+8.05%1.55B
+14.45%722.55M
-12.98%3.04B
-17.80%2.15B
-25.09%1.44B
-42.70%631.31M
-21.51%3.49B
-19.54%2.61B
-12.83%1.92B
-5.84%1.10B
-5.89%4.45B
-4.02%3.25B
-2.32%2.20B
-2.97%1.17B
-5.86%4.73B
-10.13%3.39B
-9.53%2.25B
-3.91%1.21B
+2.86%5.02B
Administrative Expenses
-10.20%835.55M
-10.86%549.45M
-10.59%269.86M
-7.79%1.21B
-5.02%930.47M
+0.34%616.39M
-10.19%301.81M
+14.57%1.31B
+38.62%979.69M
+23.89%614.30M
+18.75%336.05M
+22.93%1.14B
-18.31%706.77M
-17.14%495.86M
-14.45%283.00M
-18.64%929.03M
-1.65%865.19M
+1.56%598.46M
+3.27%330.78M
+12.90%1.14B
Research and Development
+3.23%1.69B
+15.69%1.21B
+21.07%586.14M
+1.60%2.21B
+3.06%1.63B
-2.78%1.05B
-3.72%484.12M
+11.68%2.17B
-4.89%1.58B
+0.21%1.08B
+2.27%502.82M
+8.27%1.94B
+38.30%1.67B
+28.99%1.08B
+17.89%491.66M
+3.37%1.80B
+1.27%1.20B
+8.87%834.07M
-0.35%417.05M
+13.70%1.74B
Financial Expense
-16.22%38.87M
+24.86%39.58M
+183.70%11.71M
+8.04%71.50M
-14.87%46.40M
+15.92%31.70M
-75.48%4.13M
-71.69%66.18M
-73.51%54.50M
-83.52%27.34M
-82.43%16.83M
-51.28%233.76M
-41.05%205.77M
-30.80%165.87M
-24.75%95.81M
-5.10%479.83M
-7.66%349.09M
-4.67%239.70M
+4.16%127.32M
-14.64%505.65M
-Interest Financial Expense
-18.44%68.30M
-11.03%47.83M
-12.85%23.12M
-32.18%102.84M
-32.24%83.74M
-39.94%53.76M
-44.32%26.52M
-58.06%151.62M
-57.56%123.59M
-61.06%89.51M
-61.94%47.64M
-23.92%361.54M
-14.79%291.20M
-2.95%229.86M
+0.30%125.17M
-8.32%475.22M
-12.33%341.72M
-7.06%236.86M
-0.32%124.79M
-6.58%518.34M
-Interest Financial Income
+22.19%-39.36M
-4.62%-23.93M
-6.36%-13.48M
-13.71%-81.42M
+9.60%-50.58M
+44.17%-22.87M
+43.20%-12.67M
+30.88%-71.60M
+26.29%-55.95M
+15.04%-40.96M
-33.29%-22.31M
-134.19%-103.59M
-122.55%-75.91M
-107.46%-48.22M
-115.35%-16.74M
-51.50%-44.23M
-59.71%-34.11M
-76.74%-23.24M
-24.42%-7.77M
+3.89%-29.20M
Credit Impairment Loss
+24.23%-27.36M
+13.99%-24.35M
-114.18%-13.73M
+78.47%-23.50M
+52.98%-36.11M
+59.38%-28.31M
+86.17%-6.41M
-137.32%-109.13M
+0.71%-76.79M
-88.14%-69.70M
-411.67%-46.37M
+26.41%-45.98M
-80.31%-77.34M
+12.40%-37.05M
-18.19%-9.06M
-40.54%-62.49M
-248.21%-42.89M
-327.32%-42.29M
+7.54%-7.67M
+13.37%-44.47M
Asset Impairment Loss
+14.62%-57.10M
+14.62%-57.10M
--0.00
+11.00%-116.22M
-119.29%-66.88M
-156.77%-66.88M
--0.00
-0.03%-130.59M
+34.55%-30.50M
+44.15%-26.05M
----
-195.95%-130.55M
-65.77%-46.60M
-88.97%-46.63M
-400.64%-14.76M
+12.52%-44.11M
+4.49%-28.11M
+16.15%-24.68M
--4.91M
+12.28%-50.43M
Fair Value Change Income
+63.76%35.08M
+21.66%18.42M
-5.70%7.20M
+38.76%27.61M
+56.61%21.42M
+177.01%15.14M
+159.62%7.63M
+35.67%19.90M
+15787.77%13.68M
+67.43%5.47M
+99.02%2.94M
+48.73%14.67M
-102.71%-87.18K
+82.19%3.26M
-38.96%1.48M
+104.27%9.86M
+127.39%3.22M
+1433.00%1.79M
+519081.97%2.42M
+1046.32%4.83M
Investment income
-14.13%152.51M
-17.05%110.37M
+2.64%62.93M
-39.01%210.41M
-38.39%177.60M
-37.75%133.06M
-45.17%61.31M
-3.86%345.02M
+7.97%288.27M
+24.71%213.76M
+25.29%111.84M
+52.99%358.88M
+55.18%266.98M
+56.41%171.41M
+74.91%89.26M
+9.19%234.58M
+27.39%172.05M
+140.77%109.59M
+32.20%51.03M
+126.55%214.83M
-Investment Income Associates
-9.07%144.53M
-16.75%102.91M
+1.00%59.16M
-42.93%182.89M
-41.81%158.95M
-40.75%123.61M
-47.95%58.58M
-8.99%320.47M
+5.32%273.16M
+19.85%208.63M
-50.67%112.56M
+54.30%352.11M
+65.32%259.35M
+78.41%174.07M
+500.32%228.19M
+79.25%228.19M
+21.27%156.88M
+138.22%97.57M
+2.60%38.01M
+46.61%127.30M
Asset Deal Income
-144.40%-2.55M
-80.18%1.29M
+93.26%1.15M
+558.82%5.32M
+552.96%5.74M
+373.13%6.49M
-7.51%597.48K
-69.26%807.54K
-53.87%879.45K
-16.23%1.37M
+156.42%646.02K
-51.34%2.63M
-51.70%1.91M
-60.80%1.64M
-128.15%-1.15M
+168.01%5.40M
+130.39%3.95M
+138.65%4.18M
+256.05%4.07M
+60.39%-7.94M
Other Revenues
-33.29%177.38M
-30.47%131.47M
-56.60%29.83M
+0.44%340.28M
+10.49%265.90M
-3.26%189.08M
-38.54%68.72M
+21.89%338.78M
+34.12%240.64M
+39.59%195.46M
+41.66%111.82M
+17.19%277.94M
+3.26%179.43M
-0.76%140.02M
+156.41%78.93M
+9.76%237.18M
+21.67%173.77M
+32.81%141.09M
-14.03%30.78M
-33.46%216.09M
Operating Profit
-21.97%1.39B
-40.72%897.21M
-55.09%356.49M
-43.04%2.52B
-53.28%1.78B
-48.03%1.51B
-51.38%793.74M
+21.13%4.43B
+46.68%3.81B
+54.86%2.91B
+44.77%1.63B
+66.46%3.65B
+40.59%2.60B
+71.44%1.88B
+238.15%1.13B
+66.32%2.20B
+98.46%1.85B
+110.94%1.10B
+88.32%333.47M
+30.68%1.32B
Add:Non-operating Income
+15223.71%711.09M
+28556.32%708.10M
+9362.61%101.29M
+818.43%80.91M
-24.70%4.64M
-19.09%2.47M
-36.79%1.07M
-25.69%8.81M
+36.48%6.16M
+42.54%3.05M
+196.74%1.69M
+59.93%11.86M
+93.00%4.52M
+66.06%2.14M
+54.58%570.68K
+123.45%7.41M
+17.29%2.34M
+1.15%1.29M
+31.44%369.17K
-73.67%3.32M
Less:Non-operating Expense
-10.87%120.88M
-46.95%52.12M
-22.60%16.74M
+32.29%198.13M
+22.75%135.62M
+96.80%98.26M
+131.35%21.62M
+75.02%149.77M
+96.59%110.48M
+87.39%49.93M
-25.88%9.35M
-36.44%85.57M
-43.52%56.20M
-22.83%26.64M
+28.42%12.61M
-7.49%134.64M
+226.13%99.51M
+97.78%34.52M
+75.91%9.82M
+115.52%145.54M
Gross Profit
+20.03%1.98B
+9.56%1.55B
-42.96%441.05M
-43.91%2.40B
-55.50%1.65B
-50.52%1.42B
-52.41%773.18M
+19.69%4.29B
+45.56%3.71B
+54.38%2.87B
+45.65%1.62B
+73.14%3.58B
+45.44%2.55B
+74.49%1.86B
+244.29%1.12B
+75.60%2.07B
+93.97%1.75B
+111.12%1.06B
+88.63%324.02M
+23.31%1.18B
Less:Income tax
-49.40%204.50M
-58.22%126.92M
-127.86%-31.65M
-42.97%526.62M
-48.49%404.16M
-53.21%303.79M
-66.49%113.60M
-1.11%923.40M
+94.82%784.66M
+134.70%649.29M
+118.01%338.99M
+156.75%933.79M
+37.88%402.77M
+52.63%276.65M
+193.29%155.50M
+17.51%363.70M
+86.87%292.10M
+212.64%181.26M
+208.20%53.02M
+89.23%309.50M
Net Profit
+42.57%1.77B
+28.05%1.43B
-28.33%472.70M
-44.16%1.88B
-57.39%1.24B
-49.73%1.11B
-48.70%659.59M
+27.03%3.36B
+36.30%2.92B
+40.31%2.22B
+33.93%1.29B
+55.30%2.65B
+46.96%2.14B
+78.98%1.58B
+254.27%960.07M
+96.31%1.70B
+95.45%1.46B
+97.92%882.31M
+75.32%271.00M
+9.68%868.12M
Net Profit from Continuing Operations
+42.57%1.77B
+28.05%1.43B
-28.33%472.70M
-44.16%1.88B
-57.39%1.24B
-49.73%1.11B
-48.70%659.59M
+27.03%3.36B
+36.30%2.92B
+40.31%2.22B
+33.93%1.29B
+55.30%2.65B
+46.96%2.14B
+78.98%1.58B
+254.27%960.07M
+96.31%1.70B
+95.45%1.46B
+97.92%882.31M
+75.32%271.00M
+9.68%868.12M
Net Income from Discontinuing Operating
----
----
----
----
----
----
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
----
Less:Minority Profit
+597.45%307.61M
+163.62%298.49M
-74.78%19.00M
-58.86%175.28M
-90.20%44.10M
-72.76%113.23M
-70.98%75.34M
+123.62%426.06M
+150.46%450.08M
+136.92%415.67M
+78.28%259.61M
+17379.60%190.53M
+240.06%179.70M
+1132.50%175.44M
+814.69%145.62M
+99.53%-1.10M
+151.71%52.84M
+130.28%14.23M
+2.35%-20.38M
-518.42%-234.44M
Net Profit of Parent Company Owners
+22.18%1.47B
+12.71%1.13B
-22.34%453.70M
-42.03%1.70B
-51.41%1.20B
-44.41%1.00B
-43.07%584.24M
+19.53%2.94B
+25.85%2.47B
+28.24%1.80B
+26.00%1.03B
+44.03%2.46B
+39.70%1.96B
+61.71%1.40B
+179.52%814.45M
+54.67%1.71B
+65.68%1.41B
+76.15%868.08M
+66.08%291.37M
+32.94%1.10B
Basic EPS
+22.67%0.92
+12.70%0.71
-21.62%0.29
-42.47%1.07
-52.23%0.75
-45.22%0.63
-44.78%0.37
+10.06%1.86
+16.30%1.57
+18.56%1.15
+17.54%0.67
+38.52%1.69
+35.00%1.35
+56.45%0.97
+185.00%0.57
+56.41%1.22
+66.67%1.00
+77.14%0.62
+66.67%0.20
+34.48%0.78
Diluted EPS
+22.67%0.92
+12.70%0.71
-21.62%0.29
-42.47%1.07
-52.23%0.75
-45.22%0.63
-44.78%0.37
+16.98%1.86
+23.62%1.57
+26.37%1.15
+26.42%0.67
+38.26%1.59
+33.68%1.27
+51.67%0.91
+165.00%0.53
+47.44%1.15
+58.33%0.95
+71.43%0.60
+66.67%0.20
+34.48%0.78
Other Composite Income
-36.55%-59.08M
+0.71%-39.31M
-811.63%-57.11M
-564.40%-51.73M
-145.56%-43.27M
-295.03%-39.59M
-641.12%-6.26M
+118.31%11.14M
-124.00%-17.62M
-76.68%20.30M
-100.35%-845.21K
-125.22%-60.84M
-72.62%73.41M
-24.74%87.05M
+1312.52%241.24M
+406.74%241.24M
+930.49%268.13M
+424.95%115.67M
-785.87%-19.90M
+40.29%-78.65M
Other Composite Income of Parent Company Owners
-58.46%-61.15M
+9.42%-34.99M
-626.26%-56.72M
-448.85%-49.43M
-177.22%-38.59M
-291.73%-38.63M
-439.69%-7.81M
+123.47%14.17M
-119.67%-13.92M
-76.21%20.15M
-100.61%-1.45M
-125.51%-60.37M
-72.90%70.76M
-25.01%84.70M
+1321.41%236.68M
+419.93%236.68M
+914.57%261.15M
+421.12%112.95M
-906.88%-19.38M
+45.04%-73.98M
Other Composite Income of Minority Owners
+144.30%2.07M
-350.28%-4.32M
-125.23%-389.81K
+24.26%-2.30M
-26.40%-4.68M
-734.75%-959.08K
+156.77%1.55M
-541.67%-3.03M
-239.56%-3.70M
-93.58%151.09K
-86.81%601.78K
-110.35%-472.44K
-62.03%2.65M
-13.45%2.35M
+980.31%4.56M
+197.77%4.56M
+3195.79%6.98M
+744.00%2.72M
-203.83%-518.41K
-261.39%-4.67M
Total Composite Income
+42.78%1.72B
+29.11%1.39B
-36.39%415.60M
-45.88%1.83B
-58.62%1.20B
-51.96%1.07B
-49.16%653.32M
+30.45%3.37B
+30.99%2.90B
+34.20%2.24B
+6.96%1.28B
+32.91%2.59B
+28.39%2.22B
+66.96%1.67B
+378.41%1.20B
+146.43%1.95B
+141.86%1.73B
+143.29%997.98M
+59.46%251.10M
+19.66%789.47M
Total Composite Income of Parent Company Owners
+20.98%1.41B
+13.60%1.09B
-31.13%396.99M
-43.98%1.65B
-52.70%1.16B
-47.15%962.00M
-43.75%576.43M
+23.14%2.95B
+20.79%2.46B
+22.29%1.82B
-2.51%1.02B
+23.36%2.40B
+22.05%2.03B
+51.72%1.49B
+286.45%1.05B
+88.81%1.94B
+104.18%1.67B
+114.37%981.03M
+52.94%272.00M
+48.05%1.03B
Total Composite Income of Minority Owners
+685.40%309.68M
+162.02%294.18M
-75.80%18.61M
-59.11%172.98M
-91.17%39.43M
-73.00%112.27M
-70.45%76.89M
+122.58%423.03M
+144.79%446.38M
+133.87%415.82M
+73.27%260.22M
+5391.29%190.05M
+204.81%182.35M
+948.81%177.80M
+818.80%150.18M
+101.45%3.46M
+158.41%59.82M
+135.73%16.95M
-2.59%-20.89M
-582.83%-239.11M
Deadline
Sep 30, 2026
Jun 30, 2026
Mar 31, 2026
Dec 31, 2025
Sep 30, 2025
Jun 30, 2025
Mar 31, 2025
Dec 31, 2024
Sep 30, 2024
Jun 30, 2024
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Accounting Standard
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
2026/Q92026/H12026/Q12025/FY2025/Q92025/H12025/Q12024/FY2024/Q92024/H12024/Q12023/FY2023/Q92023/H12023/Q12022/FY2022/Q92022/H12022/Q12021/FY

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.